Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:3056-3062

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheu, J.-R.
Right arrow Articles by Yen, M.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheu, J.-R.
Right arrow Articles by Yen, M.-H.
Related Collections
Right arrow Coagulation and fibronolysis
Right arrow Platelets

(Circulation. 1999;99:3056-3062.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Reduction in Lipopolysaccharide-Induced Thrombocytopenia by Triflavin in a Rat Model of Septicemia

Joen-Rong Sheu, PhD; Wei-Chung Hung, MS; Ching-Hsiang Wu, PhD; Ming-Chieh Ma, MS; Ya-Chen Kan, MS; Chien-Huang Lin, PhD; Ming-Shyan Lin, MD, PhD; Hsiung-Ning Luk, MD, PhD; Mao-Hsiung Yen, PhD

From the Graduate Institute of Medical Sciences (J.-R.S., M.-C.M., Y.-C.K., C.-H.L.), the Department of Anatomy (C.-H.W.), Taipei Medical College; Institute of Life Sciences (W.-C.H.), Institute of Medical Sciences (M.-S.L.), the Department of Pharmacology (H.-N.L., M.-H.Y.), National Defense Medical Center, Taipei, Taiwan.

Correspondence to Dr Joen-Rong Sheu, Graduate Institute of Medical Sciences, Taipei Medical College, No. 250, Wu-Shing St, Taipei 110, Taiwan. E-mail sheujr{at}tmc.edu.tw

Background—Thrombocytopenia frequently occurs early in the course of Gram-negative bacterial infections. Triflavin, an Arg-Gly-Asp–containing disintegrin, has been suggested to interfere with the interaction of fibrinogen with the glycoprotein IIb/IIIa complex. The present study was undertaken to determine whether triflavin could prevent thrombocytopenia in lipopolysaccharide (LPS)-treated rats.

Methods and Results—In this study, 51Cr-labeled platelets were used to assess blood and tissue platelet accumulation after LPS challenge. The administration of LPS (4 mg/kg IV bolus) for 4 hours induced a reduction in radiolabeled platelets in blood and an obvious accumulation of platelets in liver. Triflavin (500 µg/kg) but not GRGDS (20 mg/kg) significantly prevented the alteration of radiolabeled platelet distribution in blood and liver when induced by LPS. Furthermore, triflavin but not GRGDS markedly suppressed the elevation in plasma thromboxane B2 concentration within the 4-hour period of LPS administration. In LPS-treated rats, the 5-hydroxytryptamine level was lower in the blood and higher in the liver compared with levels in normal saline–treated rats. Pretreatment with triflavin (500 µg/kg) significantly reversed the 5-hydroxytryptamine concentration in blood and liver of LPS-treated rats. In histological examinations and platelet adhesion assay, triflavin markedly inhibited the adhesion of platelets to subendothelial matrixes in vivo and in vitro.

Conclusions—The results indicate that triflavin effectively prevents thrombocytopenia, possibly through the following 2 mechanisms: (1) Triflavin markedly inhibits platelet aggregation, resulting in decreased thromboxane A2 formation. (2) It inhibits the adhesion of platelets to subendothelial matrixes, thereby leading to a reversal in the distribution of platelets in blood and liver in LPS-treated rats.


Key Words: platelets • platelet aggregation inhibitors • peptides • thromboxane




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Hsiao, J. J. Lee, K. H. Lin, C. H. Shen, T. H. Fong, D. S. Chou, and J. R. Sheu
Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: In vitro and in vivo studies
Cardiovasc Res, September 1, 2007; 75(4): 782 - 792.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Hsiao, K. H. Lin, Y. Chang, T. L. Chen, N. H. Tzu, D. S. Chou, and J. R. Sheu
Protective Mechanisms of Inosine in Platelet Activation and Cerebral Ischemic Damage
Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1998 - 2004.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. R. Sheu, G. Hsiao, M. Y. Shen, Y. Wang, K. H. Lin, C. H. Lin, and D. S. Chou
Inhibitory Mechanisms of Metallothionein on Platelet Aggregation in In Vitro and Platelet Plug Formation in In Vivo Experiments
Experimental Biology and Medicine, December 1, 2003; 228(11): 1321 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
W. C. Aird
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Mayo Clin. Proc., July 1, 2003; 78(7): 869 - 881.
[Abstract] [PDF]


Home page
PediatricsHome page
J. D. Guida, A. M. Kunig, K. H. Leef, S. E. McKenzie, and D. A. Paul
Platelet Count and Sepsis in Very Low Birth Weight Neonates: Is There an Organism-Specific Response?
Pediatrics, June 1, 2003; 111(6): 1411 - 1415.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. C. Aird
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Blood, May 15, 2003; 101(10): 3765 - 3777.
[Abstract] [Full Text] [PDF]